EGFR , KRAS , BRAF and HER2 testing in metastatic lung adenocarcinoma: Value of testing on samples with poor specimen adequacy and analysis of discrepancies-Reference-Cited by-同舟云学术

EGFR , KRAS , BRAF and HER2 testing in metastatic lung adenocarcinoma: Value of testing on samples with poor specimen adequacy and analysis of discrepancies

Published:2017-12 Issue:3 Volume:103 Page:306-310
ISSN:0014-4800
Container-title:Experimental and Molecular Pathology
language:en
Short-container-title:Experimental and Molecular Pathology

Author:

Forest Fabien,Stachowicz Marie-Laure,Casteillo François,Karpathiou Georgia^ORCID,Gouzy-Grosjean Fabienne,Guilaubey Colette,Cottier Michèle,Beal Julie,Clemenson Alix,Péoc'h Michel

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Pathology and Forensic Medicine

Reference17 articles.

1. Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT);Barlesi;Lancet,2016

2. A proposal for cellularity assessment for EGFR mutational analysis with a correlation with DNA yield and evaluation of the number of sections obtained from cell blocks for immunohistochemistry in non-small cell lung carcinoma;da Cunha Santos;J. Clin. Pathol.,2016

3. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples;Ellison;J. Clin. Pathol.,2013

4. Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies;Ilie;Ann. Oncol.,2016

5. A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening;Janne;Clin. Cancer Res.,2006

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spread Through Air Spaces in Stage I to III Resected Lung Adenocarcinomas;American Journal of Surgical Pathology;2024-02-01

2. Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets;Therapeutic Advances in Medical Oncology;2024-01

3. Towards a clinically applicable histomolecular classification of lung adenocarcinomas?;Translational Lung Cancer Research;2023-05

4. Real-world data of EGFR mutation testing in Chinese non-small cell carcinoma: Low tumor cell number and tumor cellularity can be accepted;Pathology - Research and Practice;2022-08

5. Anti-CK7/CK20 Immunohistochemistry Did Not Associate with the Metastatic Site in TTF-1-Negative Lung Cancer;Diagnostics;2022-06-29